Corporate Governance

Protagenic Therapeutics’ corporate governance practices are in-line with industry norms.

Audit Committee

Compensation Committee

Nominating and Corporate Governance Committee

Science Committee

Clinical and Regulatory Affairs Committee

Board Diversity Matrix (As of October 20, 2022)

Board Size
Total Number of Directors6
FemaleMaleNon-BinaryDid not Disclose Gender
Gender:
Directors1500
Number of Directors who identify in Any of the Categories Below
African American or Black0000
Alaskan Native or Native American0000
Asian (other than South Asian)0000
South Asian0000
Hispanic or Latinx0000
Native Hawaiian or Pacific Islander0000
White1500
Two or More Races or Ethnicities0000
LGBTQ+1
Persons with Disabilities0

Board Diversity Matrix (As of October 20, 2022)

Board Size
Total Number of Directors6
Gender:
DirectorsFemale1
Male5
Non-Binary0
Did not Disclose Gender0
Number of Directors who identify in Any of the Categories Below
African American or BlackFemale0
Male0
Non-Binary0
Did not Disclose Gender0
Alaskan Native or Native AmericanFemale0
Male0
Non-Binary0
Did not Disclose Gender0
Asian (other than South Asian)Female0
Male0
Non-Binary0
Did not Disclose Gender0
South AsianFemale0
Male0
Non-Binary0
Did not Disclose Gender0
Hispanic or LatinxFemale0
Male0
Non-Binary0
Did not Disclose Gender0
Native Hawaiian or Pacific IslanderFemale0
Male0
Non-Binary0
Did not Disclose Gender0
WhiteFemale1
Male5
Non-Binary0
Did not Disclose Gender0
Two or More Races or EthnicitiesFemale0
Male0
Non-Binary0
Did not Disclose Gender0
LGBTQ+1
Persons with Disabilities0

© 2021 Protagenic Therapeutics, Inc.